Abstract
Objective
microRNAs (miRNAs) play critical roles in embryogenesis, cell differentiation and the pathogenesis of several human diseases, including systemic lupus erythematosus (SLE). Toll-like receptors (TLRs) are also known to exert crucial functions in the immune response activation occurring in the pathogenesis of autoimmune diseases like SLE. Herein, the current study aimed to explore the potential role of miR-152-3p in TLR-mediated inflammatory response in SLE.
Methods
We determined the miR-152-3p expression profiles in CD4+ T cells and peripheral blood mononuclear cells (PBMCs) harvested from patients with SLE and healthy controls, and analyzed the correlation between miR-152-3p expression and clinicopathological parameters. CD70 and CD40L expression patterns in CD4+ T cells were assessed by RT-qPCR and flow cytometry. ChIP was adopted to determine the enrichment of DNA methyltransferase 1 (DNMT1) in the promoter region of myeloid differentiation factor 88 (MyD88).
Results
The obtained findings revealed that miR-152-3p was highly-expressed in CD4+ T cells and PBMCs of patients with SLE, and this high expression was associated with facial erythema, joint pain, double-stranded DNA, and IgG antibody. DNMT1 could be enriched in the MyD88 promoter, and miR-152-3p inhibited the methylation of MyD88 by targeting DNMT1. We also found that silencing miR-152-3p inhibited MyD88 expression not only to repress the autoreactivity of CD4+ T cells and but also to restrain their cellular inflammation, which were also validated in vivo.
Conclusion
Our study suggests that miR-152-3p promotes TLR-mediated inflammatory response in CD4+ T cells by regulating the DNMT1/MyD88 signaling pathway, which highlights novel anti-inflammatory target for SLE treatment.
Similar content being viewed by others
Data availability
The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- miRNAs:
-
MicroRNAs
- SLE:
-
Systemic lupus erythematosus
- MyD88:
-
Myeloid differentiation factor 88
- PBMCs:
-
Peripheral blood mononuclear cells
- PB:
-
Peripheral blood
- ELISA:
-
Enzyme linked-immunosorbent assay
- MSP:
-
Methylation-specific PCR
- CHIP:
-
Chromatin immunoprecipitation
References
Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2019. https://doi.org/10.1007/s12519-019-00229-3.
Becker LV, Passos DF, Leal DBR, Morsch VM, Schetinger MRC. ATP signaling and NTPDase in systemic lupus erythematosus (SLE). Immunobiology. 2019;224:419–26.
Yin ZJ, Ju BM, Zhu L, Hu N, Luo J, He M, Feng XY, Lv XH, Pu D, He L. Increased CD4(+)CD25(−)Foxp3(+) T cells in Chinese systemic lupus erythematosus: correlate with disease activity and organ involvement. Lupus. 2018;27:2057–68.
Quiroz EN, Quiroz RN, Lugo LP, Martinez GA, Escorcia LG, Torres HG, Bonfanti AC, Marmolejo MDC, Sanchez E, Camacho JLV, Lorenzi H, Torres A, Navarro KF, Rodriguez PN, Villa JL, Fernandez-Ponce C. Integrated analysis of microRNA regulation and its interaction with mechanisms of epigenetic regulation in the etiology of systemic lupus erythematosus. PLoS ONE. 2019;14:e0218116.
Su X, Ye L, Chen X, Zhang H, Zhou Y, Ding X, Chen D, Lin Q, Chen C. MiR-199-3p promotes ERK-mediated IL-10 production by targeting poly (ADP-ribose) polymerase-1 in patients with systemic lupus erythematosus. Chem Biol Interact. 2019;306:110–6.
Geng L, Tang X, Zhou K, Wang D, Wang S, Yao G, Chen W, Gao X, Chen W, Shi S, Shen N, Feng X, Sun L. MicroRNA-663 induces immune dysregulation by inhibiting TGF-beta1 production in bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Cell Mol Immunol. 2019;16:260–74.
Luo S, Ding S, Liao J, Zhang P, Liu Y, Zhao M, Lu Q. Excessive miR-152-3p results in increased BAFF expression in SLE B-cells by inhibiting the KLF5 expression. Front Immunol. 2019;10:1127.
Wu Z, Mei X, Ying Z, Sun Y, Song J, Shi W. Ultraviolet B inhibition of DNMT1 activity via AhR activation dependent SIRT1 suppression in CD4+ T cells from systemic lupus erythematosus patients. J Dermatol Sci. 2017;86:230–7.
Tsuruta T, Kozaki K, Uesugi A, Furuta M, Hirasawa A, Imoto I, Susumu N, Aoki D, Inazawa J. miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. Cancer Res. 2011;71:6450–62.
Xu Q, Jiang Y, Yin Y, Li Q, He J, Jing Y, Qi YT, Xu Q, Li W, Lu B, Peiper SS, Jiang BH, Liu LZ. A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. J Mol Cell Biol. 2013;5:3–13.
Zhang X, Xu X, Shen Y, Fang Y, Zhang J, Bai Y, Gu S, Wang R, Chen T, Li J. Myeloid differentiation factor 88 (Myd88) is involved in the innate immunity of black carp (Mylopharyngodon piceus) defense against pathogen infection. Fish Shellfish Immunol. 2019;94:220–9.
Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature. 2007;447:972–8.
Ma K, Li J, Fang Y, Lu L. Roles of B cell-intrinsic TLR signals in systemic lupus erythematosus. Int J Mol Sci. 2015;16:13084–105.
Meng R, Li D, Feng Z, Xu Q. MyD88 hypermethylation mediated by DNMT1 is associated with LTA-induced inflammatory response in human odontoblast-like cells. Cell Tissue Res. 2019;376:413–23.
Engelbertsen D, Rattik S, Wigren M, Vallejo J, Marinkovic G, Schiopu A, Bjorkbacka H, Nilsson J, Bengtsson E. IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis. Cardiovasc Res. 2018;114:180–7.
Neubert K, Meister S, Moser K, Weisel F, Maseda D, Amann K, Wiethe C, Winkler TH, Kalden JR, Manz RA, Voll RE. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med. 2008;14:748–55.
Huang J, Wang Y, Guo Y, Sun S. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology. 2010;52:60–70.
Pacheco GV, Noh IBN, Cardenas RMV, Ramirez AVA, Villanueva RFL, Ortiz IGQ, Salomon LGA, Ruz NP, Cardenas NAR. Expression of TLR-7, MyD88, NF-kB, and INF-alpha in B lymphocytes of mayan women with systemic lupus erythematosus in Mexico. Front Immunol. 2016;7:22.
Georg I, Diaz-Barreiro A, Morell M, Pey AL, Alarcon-Riquelme ME. BANK1 interacts with TRAF6 and MyD88 in innate immune signaling in B cells. Cell Mol Immunol. 2020;17:954–65.
Pasoto SG, de Martins VAO, Bonfa E. Sjogren’s syndrome and systemic lupus erythematosus: links and risks. Open Access Rheumatol. 2019;11:33–45.
Husakova M. MicroRNAs in the key events of systemic lupus erythematosus pathogenesis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016;160:327–42.
Li HS, Ning Y, Li SB, Shao PY, Chen SJ, Ye Q, Heng X. Expression and clinical significance of miR-181a and miR-203 in systemic lupus erythematosus patients. Eur Rev Med Pharmacol Sci. 2017;21:4790–6.
Shumnalieva R, Kachakova D, Shoumnalieva-Ivanova V, Miteva P, Kaneva R, Monov S. Whole peripheral blood miR-146a and miR-155 expression levels in Systemic lupus erythematosus patients. Acta Reumatol Port. 2018;43:217–25.
Chen JQ, Papp G, Poliska S, Szabo K, Tarr T, Balint BL, Szodoray P, Zeher M. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjogren’s syndrome. PLoS ONE. 2017;12:e0174585.
Jentho E, Bodden M, Schulz C, Jung AL, Seidel K, Schmeck B, Bertrams W. microRNA-125a-3p is regulated by MyD88 in Legionella pneumophila infection and targets NTAN1. PLoS ONE. 2017;12:e0176204.
Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu G, Zhao R, Huang H, Wang X, Qiao Y, Li F, Han D, Wang L, Zhang G, Gao X. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine. Oncogene. 2014;33:378–86.
Liao W, Li M, Wu H, Jia S, Zhang N, Dai Y, Zhao M, Lu Q. Down-regulation of MBD4 contributes to hypomethylation and overexpression of CD70 in CD4(+) T cells in systemic lupus erythematosus. Clin Epigenetics. 2017;9:104.
Sun J, Shao TJ, Zhang DY, Huang XQ, Xie ZJ, Wen CP. Effect of Lang-Chuang-Ding Decoction () on DNA methylation of CD70 gene promoter in peripheral blood mononuclear cells of female patients with systemic lupus erythematosus. Chin J Integr Med. 2018;24:348–52.
Mousa TG, Omar HH, Emad R, Salama MI, Omar W, Fawzy M, Hassoba HM. The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients. Clin Rheumatol. 2019;38:777–84.
Arkatkar T, Du SW, Jacobs HM, Dam EM, Hou B, Buckner JH, Rawlings DJ, Jackson SW. B cell-derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity. J Exp Med. 2017;214:3207–17.
Raymond W, Ostli-Eilertsen G, Griffiths S, Nossent J. IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: evidence for a dual role. Eur J Rheumatol. 2017;4:29–35.
Tang Y, Tao H, Gong Y, Chen F, Li C, Yang X. Changes of serum IL-6, IL-17, and complements in systemic lupus erythematosus patients. J Interferon Cytokine Res. 2019;39:410–5.
McHugh J. Systemic lupus erythematosus: B cell-derived IL-6 promotes disease. Nat Rev Rheumatol. 2017;13:633.
Yang ZC, Xu F, Tang M, Xiong X. Association between TNF-alpha promoter-308 A/G polymorphism and systemic lupus erythematosus susceptibility: a case-control study and meta-analysis. Scand J Immunol. 2017;85:197–210.
Friedrich M, Pracht K, Mashreghi MF, Jack HM, Radbruch A, Seliger B. The role of the miR-148/-152 family in physiology and disease. Eur J Immunol. 2017;47:2026–38.
Bosisio D, Gianello V, Salvi V, Sozzani S. Extracellular miRNAs as activators of innate immune receptors. Cancer Lett. 2019;452:59–65.
Makkawi H, Hoch S, Burns E, Hosur K, Hajishengallis G, Kirschning CJ, Nussbaum G. Porphyromonas gingivalis stimulates TLR2-PI3K signaling to escape immune clearance and induce bone resorption independently of MyD88. Front Cell Infect Microbiol. 2017;7:359.
Liu Y, Liao J, Zhao M, Wu H, Yung S, Chan TM, Yoshimura A, Lu Q. Increased expression of TLR2 in CD4(+) T cells from SLE patients enhances immune reactivity and promotes IL-17 expression through histone modifications. Eur J Immunol. 2015;45:2683–93.
Van Pham L, Germaud N, Ramadan A, Thieblemont N. MyD88 modulates eosinophil and neutrophil recruitment as well as IL-17A production during allergic inflammation. Cell Immunol. 2016;310:116–22.
Acknowledgements
We give our sincere gratitude to the reviewers for their valuable suggestions.
Funding
This study is supported by the Project Program of Neurosurgical Clinical Research Center of Sichuan Province, Science and Technology Foundation of Luzhou (2015-S-45(2/5)), Science and Technology Foundation of Southwest Medical University (2017-ZRQN-180, 2017-ZRQN-110).
Author information
Authors and Affiliations
Contributions
BT and WX designed the study. XL and CH collated the data, conducted data analyses. LC, XX and TP completed the initial draft of the manuscript. LP, XY and CZ contributed to drafting the manuscript. All authors have read and approved the final submitted manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The author declares no competing interest exists.
Additional information
Handling Editor John Di Battista.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tao, B., Xiang, W., Li, X. et al. Regulation of Toll-like receptor-mediated inflammatory response by microRNA-152-3p-mediated demethylation of MyD88 in systemic lupus erythematosus. Inflamm. Res. 70, 285–296 (2021). https://doi.org/10.1007/s00011-020-01433-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-020-01433-y